EMBC - Embecta beats top-line and bottom-line estimates; updates FY24 outlook February, 09 2024 06:37 AM Embecta Corp. 2024-02-09 06:37:28 ET More on Embecta Embecta submits FDA application for type 2 diabetes insulin patch pump Embecta Non-GAAP EPS of $0.59 beats by $0.19, revenue of $281.9M beats by $10.35M Seeking Alpha’s Quant Rating on Embecta Historical earnings data for Embecta For further details see: Embecta beats top-line and bottom-line estimates; updates FY24 outlook